For E. coli growth, LB agar, LB media, defined media components including unlabeled amino acids, uracil, thiamine--HCl, nicotinic acid, biotin and buffer components were purchased from RPI corp. 3--Fluorotyrosine, thymine, cytosine, guanosine were purchased from Alfa Aesar. Magnesium chloride, manganese sulfate, succinic acid, calcium chloride and 5--fluoroindole were purchased from Sigma--Aldrich. Miniprep plasmid purification kit was purchased from Clontech.
Brd4
(1) was loaded on to a nickel--NTA affinity column and eluted with an imidazole gradient on an AKTA FPLC system monitoring the O.D. at 280 nm. Imidazole was removed from the buffer using a HiPrep column (GE) for buffer exchange into either 50 mM potassium phosphate, pH 7.4, and 100 mM NaCl or 50 mM Tris pH 7.4, 100 mM NaCl. Purified and buffer exchanged protein was treated with TEV protease for either 2 hours at room temperature or alternatively at 4 o C overnight on a rotating carrousel. The cleaved His--tag, TEV protease and uncleaved Brd4 were removed using nickel--NTA affinity resin.
Site--directed mutagenesis:
To assign the fluorinated resonances in the 19 F NMR spectrum, we mutated single tyrosine and tryptophan residues to phenylalanine using a standard PCR amplification method. One common reverse primer and forward primers containing point mutation for (Y65F, Y98F, Y118F, Y137F, Y139F, W75F and W120F) and a primer pairs for (Y97F, Y119F and W81F) were used for PCR amplification. Primer sequences are shown in Table  S1 . Parent plasmid template was digested by Dpn1 nuclease followed by transformation into E. coli BL21(DE3). Three colonies for each mutant were picked and grown in LB media containing kanamycin followed by miniprep plasmid purification (kits from Clontech). Point mutations on plasmids were confirmed by Sanger sequencing. Auxotrophic E. coli DL39(DE3) + pRARE and E. coli BL21(DE3) + pRARE cells were transformed with tyrosine and tryptophan mutation containing plasmids respectively and subjected to protein expression and purification. After several attempts Y97, Y119 and W81 mutants did not express well, and were not purified. These assignments were either inferred (last resonance unassigned for W120) or validated by binding a known ligand (Y119 vs. Y97). Table S1 . Primer sequences for point mutation of tyrosine and tryptophan to phenylalanine: Table S2 . To determine the percent incorporation for fluorinated proteins the integration values of the different deconvoluted mass peaks are entered into the following equation to determine the relative incorporation e..g, FWBrd4:
0FWBrd4 is 5FWBrd4 with no fluorine substitutions, 1FWBrd4 is 5FWBrd4 with one fluorine substitution, 2FWBrd4 has two fluorines substituted and FWBrd4 has 3 fluorines substituted. Table S2 . Deconvoluted mass spectral data of wild--type Brd4(1) as well as fluorinated variants and mutants. Only data for fully labeled or unlabeled proteins are shown. To check the secondary structural content, far--UV CD spectra (200--260 nm) of unlabeled and labeled proteins were collected using a peltier equipped temperature controlled Jasco J--815 spectropolarimeter at 25 o C. For all measurements, 20 µM (50 mM Tris buffer pH 7.4 containing 100 mM NaCl) of protein and a 1 mm cuvette path--length were used. Spectral data were collected at a scan rate of 50 nm/min with averaging of 5 spectra. Processed data were baseline corrected against spectra taken with buffer alone. Thermal Melting: Thermal stabilities of labeled and unlabeled proteins were measured by the change in ellipticity at 222 nm with the increase in temperature from 20 o C to 80 o C at the scan rate of 60 degrees/h. The Mid--point of transition was calculated by a sigmoidal fit to determine the Tm.
Isothermal titration calorimetry of unlabeled, 3FY and 5FW labeled Brd4(1):
Auto ITC200 (GE) and Nano--ITC were used to perform isothermal titration calorimetry experiments. A 3FY--Brd4(1) solution was loaded in the Auto ITC200 calorimeter and titrated with (+)--JQ1 diluted in the same buffer as protein (50 mM potassium phosphate pH 7.4, 100 mM NaCl). Note: to facilite solubility, JQ1 solutions were sonicated immediately prior to use. We used 47 µM of 3FY--Brd4(1). A 50 mM (+)--JQ1 stock solution was prepared in DMSO and diluted in the same buffer as protein at concentration of 500 µM and used for the titration. Titrations were carried out by using 2 µL per injection volume of 500 µM (+)--JQ1. Heat liberated by each injection was integrated (ΔH) and plotted against molar ratio of ligand and protein. Obtained data was fitted by using predefined one and two binding site modes. The fitting of data was not sufficient with one binding site whereas a two binding site model produced an appropriate fit, indicating a potential low affinity binding (Kd = 1.6 mM) site which could be from DMSO. The reported Kd is an average value from of two separate titrations. For binding of (+)--JQ1 (50 µM) to unlabeled Brd4(1) at 25 o C, the experiments were performed using Nano--ITC (TA Instruments). In this experiment, 550 μM unlabeled in 50 mM Tris pH 7.4, 100 mM NaCl and 4 mM DTT and 500 µM 5FW labeled proteins in 50 mM HEPES pH 7.5, 150 mM NaCl and 4 mM DTT were used as a ligand and loaded to the microsyringe (50 μL). The first injection of 0.5 μL was followed by 20 and 24 identical injections of 2 and 2.5 μL respectively with a releasing period of 8 seconds per injection with 200--300 second spacing time between injections. Control heat of dilution was measured by independent protein titration into buffer and was subtracted from the protein--ligand binding experimental data. Data was analyzed by NanoAnalyze software to calculate enthalpy of binding (ΔH) and dissociation constants (Kd). In all cases an independent binding model was used for data fitting. See Fig. S29 and Table S22 Secondary structure measurement by circular dichroism: Fig.  S1 : Far--UV spectra of unlabelled (black), 3FY (red) and 5FW (blue) labelled Brd4(1). Each spectrum was measured at 25 o C and protein concentration for each spectrum was 20 µM in 50 mM Tris buffer pH 7.4 containing 100 mM NaCl. : 1D 19 F NMR spectra of 3FY labeled wild--type and tyrosine to phenylalanine point mutated Brd4(1). Asterisks represent the position of missing peaks of corresponding mutated tyrosine. The Y118F expressed poorly, and had low stability. In the Y118F spectrum a partial resonance (which integrates to 0.49) grows in obscuring the absence of the resonance at this position. We have identified this resonance as either a degradation product or resonance from aggregation of the protein see Fig.  S5 . The two rotamers for Y98, as seen in the Y139F spectrum, aided in the assignment of the shifted Y139 resonance in the acetaminophen binding experiment. (see Fig. S8 3FY--Brd4 (+)--JQ1 titration: 5FW--Brd4 dinaciclib titration: B C Fig. S11 : 19 F NMR spectral analysis of 5FW--Brd4 demonstrating chemical shift perturbation of the W75 resonance in response to increasing concentration of dinaciclib. A) Representative 19 F NMR spectra from titration with dinaciclib. Ribbon diagram of dinaciclib bound to Brd4(1) (PDB Code: 4O70). The α--carbon of tryptophan are indicated as colored balls. Resonances not significantly perturbed are blue, resonances perturbed 0.05 ppm - 0.1 ppm are light pink, and resonances perturbed greater than 0.1 ppm or broadened significantly in a dose dependent fashion are red. B) Absolute value of chemical shift perturbation for the 5FW--Brd4(1) tryptophan resonances at 294 μM dinaciclib. C) A binding isotherm of W75 perturbation for the dinaciclib titration. 
Aromatic amino acid analysis across all 61 Bromodomains Relative to Brd4(1)

Fig. S23
: 19 F NMR spectral analysis of 5FW--Brd4 and 5FW--BPTF demonstrating chemical shift perturbation of resonances of both proteins in response to presence of BI2536. The 5FW--Brd4 W81 resonance is perturbed as it was previously in Fig. S13 , and the 5FW--BPTF W2824 resonance broadens and shifts upfield, as shown in Fig. S22 . This is indicative of intermediate exchange of BI2536 with 5FW--BPTF in the presence of 5FW--Brd4.
5FW--Brd4 and wtBPTF and wtBrdT with BI2536: Fig. S24 : 19 F NMR spectral analysis of 5FW--Brd4 demonstrating chemical shift perturbation of various resonances in response to increasing concentration of BI2536 in the presence of other bromodomains. Above, wtBrdT is shown to partially compete off BI2536 from Brd4 as there are two populations of 5FW--Brd4 present in the NMR spectrum. Protein wtBPTF is shown to not compete off BI2536 from Brd4, as there is only one population present in the NMR spectrum indicative of the fully bound state obtained from using only 5FW--Brd4 and BI2536.
Fig. S25
: 19 F NMR spectral analysis of 5FW--BPTF demonstrating chemical shift perturbation of W2824 in response to increasing concentration of (+)--JQ1. Above are 19 F NMR spectra from titration with (+)--JQ1. Small chemical shift perturbations in fast exchange at high micromolar concentrations of (+)--JQ1 could not be separated from solvent effects with just ethylene glycol, supporting selectivity of (+)--JQ1 for BET bromodomains. (1)) in response to increasing concentration of (+)--JQ1. Above are 19 F NMR spectra from titration with (+)--JQ1. Chemical shift perturbation in slow exchange regime supports strong binding with BET bromodomain BrdT(1).
Titration of 5FW--BrdT with BI2536: Fig. S27 : 19 F NMR spectral analysis of 5FW--BrdT(1) demonstrating chemical shift perturbation of fluorinated tryptophan residues (analogous to residues W81 and W75 in Brd4(1)) in response to increasing concentration of BI2536. Chemical shift perturbation in slow exchange regime supports strong binding with BET bromodomain BrdT(1).
BI2536 Binding in the presence of DMSO: Fig. S28 : 19 F NMR spectral analysis of 5FW--Brd4 and 5FW--BPTF demonstrating chemical shift perturbation of resonances of both proteins in response to presence of BI2536 while in a solution containing 1% DMSO. The 5FW--Brd4 W81 resonance is perturbed shifting upfield as it was previously in Fig. S13 , and the 5FW--BPTF W2824 resonance broadens and shifts upfield, as shown in Fig. S22 . This is indicative of intermediate exchange of BI2536 with 5FW--BPTF in the presence of 5FW--Brd4. While the 1% DMSO solution perturbs both resonances slightly, the effects of BI2536 are clearly visible for both 5FW--Brd4 and 5FW--BPTF.
ITC Binding isotherm of (+)--JQ1 with unlabeled Brd4(1) and 5FW Brd4(1) Fig.  S29 : Isothermal titration calorimetric analysis of binding of (+)--JQ1 to unlabeled (black filled circle) and 5FW labeled (open red circle) Brd4(1) at 25 o C. The study was performed by using Nano--ITC equipment (TA Instruments). In the following experiments, 550 μM unlabeled in 50 mM Tris pH 7.4, 100 mM NaCl and 4 mM DTT and 500 µM 5FW labeled proteins in 50 mM HEPES pH 7.5, 150 mM NaCl and 4 mM DTT were used as a ligand and loaded to the microsyringe (50 μL). 50 µM (+)--JQ1 solutions were made in the same buffers used for proteins. Titrations were carried out with first injection of 1.0 μL followed by 20 identical injections of 2.5 μL with a releasing period of 8 seconds per injection with 300 seconds spacing time between injections. Control heat of dilution was measured by independent protein titration into buffer and was subtracted from the protein--ligand binding experimental data. Data was analyzed by NanoAnalyze software to calculate enthalpy of binding (ΔH) and dissociation constants (Kd). In all cases an independent binding model was used for data fitting. The pre and post transition baselines show saturation behavior, which indicates no further protein ligand interaction event. 
